Madrigal Pharmaceuticals will release its third-quarter 2026 financial results on November 3, 2026, before U.S. markets open. The company will hold a live webcast at 8 a.m. ET to discuss its financial and operating performance. Madrigal focuses on treatments for metabolic dysfunction-associated steatohepatitis (MASH), with its drug Rezdiffra approved for moderate to advanced fibrosis. Investors can access the webcast via the company's website, with a replay available two hours later.
Madrigal Pharmaceuticals' upcoming Q3 2026 financial results release provides context for health sector activity on Pluang as of Oct 20, 2026 19:03 WIB. Among 150 priced health-sector US stocks, 81 rose and 62 fell. Twist Bioscience Corp (TWST) traded at USD 135.39 with a 3.13% decline and a typical hold time of 27 days, contrasting with Heron Therapeutics Inc (HRTX) at USD 0.36, down 2.63% but with a longer hold time of 37 days and a buy-dominant order activity of 58%. Sanofi SA (SNY) stood out with a 2.53% gain at USD 40.57 and a notably longer typical hold time of 95 days.
Hershey is preparing to announce its Q3 earnings on October 29, with analysts forecasting earnings per share (EPS) of $2.12, a 63% increase from last year, and revenue of $3.25 billion, up 2.3%. The company has shown strong recent performance, with Q...
3M reported strong Q3 2026 earnings with adjusted EPS of $2.50, beating estimates of $2.38, and GAAP profit rising to $1.37 billion from $834 million a year earlier. Sales reached $6.6 billion, slightly below estimates, but showed 3.3% organic growth...
Alaska Air Group is set to report Q3 2026 earnings with analysts expecting a 66.7% drop in earnings per share to $0.35, despite a 14.5% increase in revenue to $4.31 billion driven by strong travel demand. Passenger revenue is forecast to rise 10.2%, ...
Baba, an applied AI company focused on modernizing Medicare and Medicaid care, has raised $40 million in a Series A funding round led by FirstMark Capital, with participation from CVS Health Ventures and others. The funding will help Baba expand its ...
Richard Campbell-Breeden, a seasoned investment banker with 37 years of experience including 27 years at Goldman Sachs, has joined SEDA Experts LLC as Managing Director. His expertise in mergers and acquisitions, corporate finance, and governance wil...
